<DOC>
	<DOC>NCT01504529</DOC>
	<brief_summary>This is an observational, non-interventional and retrospective study in patients with advanced PD who have been treated with Rotigotine (Neupro®) as prescribed by physicians according to usual clinical practice in Spain. The Primary Objective will be to evaluate Non-Motor Symptoms (NMS) in advanced PD patients who have been treated with Rotigotine for at least 6 months.</brief_summary>
	<brief_title>Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>N 0437</mesh_term>
	<criteria>To be eligible to participate in this study, all of the following criteria must be met: Male and female ambulatory patients with Parkinson's disease diagnosis (as per the London Brain Bank diagnosis criteria) ≥6 months ago Patient aged 30 years or older at the time of Parkinson's disease diagnosis Patients who were under treatment with Rotigotine following routine clinical practice, either alone or in combination with Levodopa, and in an advanced PD dosage (≥ 8 mg/ 24 h) for at least the previous 6 months Patients under treatment with Rotigotine (≥ 8 mg/ 24 h) who were assessed twice of NMS by means of the PDNMSQ 6 months apart Patients are currently informed and have been given enough time and opportunity to think about participation (data collection) in the study and have given written informed consent Patients are not permitted to enroll in the study if any of the following criteria is met during the previous 6 months: Patients have other Parkinsonian syndrome different than Parkinson´s disease Patients have a history of Pallidotomy, Thalamotomy, Deep Brain Stimulation or Fetal Tissue Transplant Patients with Dementia, active Hallucinations or active or treated Psychosis Patients with any other neurological / psychological disorder Patients who had received Central Nervous System (CNS) active therapy (e.g. sedatives, hypnotics, antidepressants, anxiolytics, atypical neuroleptics, etc)</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Rotigotine (Neupro)</keyword>
	<keyword>Non-Motor Symptoms</keyword>
	<keyword>Advanced Parkinson's Disease</keyword>
	<keyword>Local study</keyword>
	<keyword>Spain</keyword>
	<keyword>Observational study</keyword>
	<keyword>Non-interventional study</keyword>
	<keyword>Retrospective study</keyword>
	<keyword>Post-marketing study</keyword>
	<keyword>Multicenter study</keyword>
</DOC>